Industry Research Reports

Home > Reports > Medical Devices & Consumables > Radiopharmaceuticals in Nuclear Medical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Radiopharmaceuticals in Nuclear Medical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-16

Pages: 135 Pages

Report ld: 2226294

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound. Radiopharmacology is the branch of pharmacology that specializes in these agents.

The global market for Radiopharmaceuticals in Nuclear Medical was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceuticals in Nuclear Medical, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Radiopharmaceuticals in Nuclear Medical by region & country, by Type, and by Application.

The Radiopharmaceuticals in Nuclear Medical market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceuticals in Nuclear Medical.

Market Segmentation

Report Metric
Details
Report Title
Radiopharmaceuticals in Nuclear Medical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Radiopharmaceuticals in Nuclear Medical Companies Covered
Bracco Imaging, Cambridge Isotope Laboratories, Cardinal Health, Medtronic, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group, Lantheus Medical Imaging, Nordion, Ntp Radioisotopes, Siemens Healthcare, Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries
Global Radiopharmaceuticals in Nuclear Medical Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Radiopharmaceuticals in Nuclear Medical Market, Segment by Type
Diagnostic Radiopharmaceuticals

Therapy Radiopharmaceuticals

Enriched Stable Isotopes
Global Radiopharmaceuticals in Nuclear Medical Market, Segment by Application
Diagnostic Application

Therapeutic Application

Research

Pharmaceutical

Industrial
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Radiopharmaceuticals in Nuclear Medical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Radiopharmaceuticals in Nuclear Medical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Radiopharmaceuticals in Nuclear Medical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Radiopharmaceuticals in Nuclear Medical Product Introduction
    1.2 Global Radiopharmaceuticals in Nuclear Medical Market Size Forecast
        1.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030)
        1.2.2 Global Radiopharmaceuticals in Nuclear Medical Sales Volume (2019-2030)
        1.2.3 Global Radiopharmaceuticals in Nuclear Medical Sales Price (2019-2030)
    1.3 Radiopharmaceuticals in Nuclear Medical Market Trends & Drivers
        1.3.1 Radiopharmaceuticals in Nuclear Medical Industry Trends
        1.3.2 Radiopharmaceuticals in Nuclear Medical Market Drivers & Opportunity
        1.3.3 Radiopharmaceuticals in Nuclear Medical Market Challenges
        1.3.4 Radiopharmaceuticals in Nuclear Medical Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Radiopharmaceuticals in Nuclear Medical Players Revenue Ranking (2023)
    2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Company (2019-2024)
    2.3 Global Radiopharmaceuticals in Nuclear Medical Players Sales Volume Ranking (2023)
    2.4 Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Company Players (2019-2024)
    2.5 Global Radiopharmaceuticals in Nuclear Medical Average Price by Company (2019-2024)
    2.6 Key Manufacturers Radiopharmaceuticals in Nuclear Medical Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Radiopharmaceuticals in Nuclear Medical Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Radiopharmaceuticals in Nuclear Medical
    2.9 Radiopharmaceuticals in Nuclear Medical Market Competitive Analysis
        2.9.1 Radiopharmaceuticals in Nuclear Medical Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Radiopharmaceuticals in Nuclear Medical Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Diagnostic Radiopharmaceuticals
        3.1.2 Therapy Radiopharmaceuticals
        3.1.3 Enriched Stable Isotopes
    3.2 Global Radiopharmaceuticals in Nuclear Medical Sales Value by Type
        3.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Radiopharmaceuticals in Nuclear Medical Sales Value, by Type (2019-2030)
        3.2.3 Global Radiopharmaceuticals in Nuclear Medical Sales Value, by Type (%) (2019-2030)
    3.3 Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Type
        3.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Radiopharmaceuticals in Nuclear Medical Sales Volume, by Type (2019-2030)
        3.3.3 Global Radiopharmaceuticals in Nuclear Medical Sales Volume, by Type (%) (2019-2030)
    3.4 Global Radiopharmaceuticals in Nuclear Medical Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Diagnostic Application
        4.1.2 Therapeutic Application
        4.1.3 Research
        4.1.4 Pharmaceutical
        4.1.5 Industrial
    4.2 Global Radiopharmaceuticals in Nuclear Medical Sales Value by Application
        4.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Radiopharmaceuticals in Nuclear Medical Sales Value, by Application (2019-2030)
        4.2.3 Global Radiopharmaceuticals in Nuclear Medical Sales Value, by Application (%) (2019-2030)
    4.3 Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Application
        4.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Radiopharmaceuticals in Nuclear Medical Sales Volume, by Application (2019-2030)
        4.3.3 Global Radiopharmaceuticals in Nuclear Medical Sales Volume, by Application (%) (2019-2030)
    4.4 Global Radiopharmaceuticals in Nuclear Medical Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region
        5.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region (2019-2024)
        5.1.3 Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region (2025-2030)
        5.1.4 Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region (%), (2019-2030)
    5.2 Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region
        5.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (2019-2024)
        5.2.3 Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (2025-2030)
        5.2.4 Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (%), (2019-2030)
    5.3 Global Radiopharmaceuticals in Nuclear Medical Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        5.4.2 North America Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        5.5.2 Europe Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        5.6.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        5.7.2 South America Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        5.8.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Value
        6.2.1 Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        6.3.2 United States Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Radiopharmaceuticals in Nuclear Medical Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        6.4.2 Europe Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Radiopharmaceuticals in Nuclear Medical Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        6.5.2 China Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Radiopharmaceuticals in Nuclear Medical Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        6.6.2 Japan Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Radiopharmaceuticals in Nuclear Medical Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        6.7.2 South Korea Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Radiopharmaceuticals in Nuclear Medical Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        6.8.2 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Radiopharmaceuticals in Nuclear Medical Sales Value, 2019-2030
        6.9.2 India Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Radiopharmaceuticals in Nuclear Medical Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bracco Imaging
        7.1.1 Bracco Imaging Company Information
        7.1.2 Bracco Imaging Introduction and Business Overview
        7.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.1.5 Bracco Imaging Recent Development
    7.2 Cambridge Isotope Laboratories
        7.2.1 Cambridge Isotope Laboratories Company Information
        7.2.2 Cambridge Isotope Laboratories Introduction and Business Overview
        7.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.2.5 Cambridge Isotope Laboratories Recent Development
    7.3 Cardinal Health
        7.3.1 Cardinal Health Company Information
        7.3.2 Cardinal Health Introduction and Business Overview
        7.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.3.5 Cardinal Health Recent Development
    7.4 Medtronic
        7.4.1 Medtronic Company Information
        7.4.2 Medtronic Introduction and Business Overview
        7.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Medtronic Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.4.5 Medtronic Recent Development
    7.5 Eczacibasi-Monrol
        7.5.1 Eczacibasi-Monrol Company Information
        7.5.2 Eczacibasi-Monrol Introduction and Business Overview
        7.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.5.5 Eczacibasi-Monrol Recent Development
    7.6 Fujifilm Holdings Corporation
        7.6.1 Fujifilm Holdings Corporation Company Information
        7.6.2 Fujifilm Holdings Corporation Introduction and Business Overview
        7.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.6.5 Fujifilm Holdings Corporation Recent Development
    7.7 GE Healthcare (Subsidiary Of General Electric Company)
        7.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Information
        7.7.2 GE Healthcare (Subsidiary Of General Electric Company) Introduction and Business Overview
        7.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
    7.8 IBA Group
        7.8.1 IBA Group Company Information
        7.8.2 IBA Group Introduction and Business Overview
        7.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.8.5 IBA Group Recent Development
    7.9 Lantheus Medical Imaging
        7.9.1 Lantheus Medical Imaging Company Information
        7.9.2 Lantheus Medical Imaging Introduction and Business Overview
        7.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.9.5 Lantheus Medical Imaging Recent Development
    7.10 Nordion
        7.10.1 Nordion Company Information
        7.10.2 Nordion Introduction and Business Overview
        7.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.10.5 Nordion Recent Development
    7.11 Ntp Radioisotopes
        7.11.1 Ntp Radioisotopes Company Information
        7.11.2 Ntp Radioisotopes Introduction and Business Overview
        7.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.11.5 Ntp Radioisotopes Recent Development
    7.12 Siemens Healthcare
        7.12.1 Siemens Healthcare Company Information
        7.12.2 Siemens Healthcare Introduction and Business Overview
        7.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.12.5 Siemens Healthcare Recent Development
    7.13 Taiyo Nippon Sanso Corporation
        7.13.1 Taiyo Nippon Sanso Corporation Company Information
        7.13.2 Taiyo Nippon Sanso Corporation Introduction and Business Overview
        7.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.13.5 Taiyo Nippon Sanso Corporation Recent Development
    7.14 Urenco Limited
        7.14.1 Urenco Limited Company Information
        7.14.2 Urenco Limited Introduction and Business Overview
        7.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Urenco Limited Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.14.5 Urenco Limited Recent Development
    7.15 Rotem Industries
        7.15.1 Rotem Industries Company Information
        7.15.2 Rotem Industries Introduction and Business Overview
        7.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Rotem Industries Radiopharmaceuticals in Nuclear Medical Product Offerings
        7.15.5 Rotem Industries Recent Development

 8 Industry Chain Analysis
    8.1 Radiopharmaceuticals in Nuclear Medical Industrial Chain
    8.2 Radiopharmaceuticals in Nuclear Medical Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Radiopharmaceuticals in Nuclear Medical Sales Model
        8.5.2 Sales Channel
        8.5.3 Radiopharmaceuticals in Nuclear Medical Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Radiopharmaceuticals in Nuclear Medical Market Trends
    Table 2. Radiopharmaceuticals in Nuclear Medical Market Drivers & Opportunity
    Table 3. Radiopharmaceuticals in Nuclear Medical Market Challenges
    Table 4. Radiopharmaceuticals in Nuclear Medical Market Restraints
    Table 5. Global Radiopharmaceuticals in Nuclear Medical Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2019-2024)
    Table 7. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Company (2019-2024) & (K MT)
    Table 8. Global Radiopharmaceuticals in Nuclear Medical Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Radiopharmaceuticals in Nuclear Medical Price by Company (2019-2024) & (USD/MT)
    Table 10. Key Manufacturers Radiopharmaceuticals in Nuclear Medical Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Radiopharmaceuticals in Nuclear Medical
    Table 13. Global Radiopharmaceuticals in Nuclear Medical Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
    Table 22. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Type (2019-2024) & (K MT)
    Table 23. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Type (2025-2030) & (K MT)
    Table 24. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Radiopharmaceuticals in Nuclear Medical Price by Type (2019-2024) & (USD/MT)
    Table 27. Global Radiopharmaceuticals in Nuclear Medical Price by Type (2025-2030) & (USD/MT)
    Table 28. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
    Table 34. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2019-2024) & (K MT)
    Table 35. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2025-2030) & (K MT)
    Table 36. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Radiopharmaceuticals in Nuclear Medical Price by Application (2019-2024) & (USD/MT)
    Table 39. Global Radiopharmaceuticals in Nuclear Medical Price by Application (2025-2030) & (USD/MT)
    Table 40. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region (2019-2024) & (%)
    Table 44. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region (2025-2030) & (%)
    Table 45. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
    Table 46. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (2019-2024) & (K MT)
    Table 47. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (2025-2030) & (K MT)
    Table 48. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Radiopharmaceuticals in Nuclear Medical Average Price by Region (2019-2024) & (USD/MT)
    Table 51. Global Radiopharmaceuticals in Nuclear Medical Average Price by Region (2025-2030) & (USD/MT)
    Table 52. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Volume, (2019-2024) & (K MT)
    Table 56. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Volume, (2025-2030) & (K MT)
    Table 57. Bracco Imaging Company Information
    Table 58. Bracco Imaging Introduction and Business Overview
    Table 59. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 60. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 61. Bracco Imaging Recent Development
    Table 62. Cambridge Isotope Laboratories Company Information
    Table 63. Cambridge Isotope Laboratories Introduction and Business Overview
    Table 64. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 65. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 66. Cambridge Isotope Laboratories Recent Development
    Table 67. Cardinal Health Company Information
    Table 68. Cardinal Health Introduction and Business Overview
    Table 69. Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 70. Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 71. Cardinal Health Recent Development
    Table 72. Medtronic Company Information
    Table 73. Medtronic Introduction and Business Overview
    Table 74. Medtronic Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 75. Medtronic Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 76. Medtronic Recent Development
    Table 77. Eczacibasi-Monrol Company Information
    Table 78. Eczacibasi-Monrol Introduction and Business Overview
    Table 79. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 80. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 81. Eczacibasi-Monrol Recent Development
    Table 82. Fujifilm Holdings Corporation Company Information
    Table 83. Fujifilm Holdings Corporation Introduction and Business Overview
    Table 84. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 85. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 86. Fujifilm Holdings Corporation Recent Development
    Table 87. GE Healthcare (Subsidiary Of General Electric Company) Company Information
    Table 88. GE Healthcare (Subsidiary Of General Electric Company) Introduction and Business Overview
    Table 89. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 90. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 91. GE Healthcare (Subsidiary Of General Electric Company) Recent Development
    Table 92. IBA Group Company Information
    Table 93. IBA Group Introduction and Business Overview
    Table 94. IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 95. IBA Group Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 96. IBA Group Recent Development
    Table 97. Lantheus Medical Imaging Company Information
    Table 98. Lantheus Medical Imaging Introduction and Business Overview
    Table 99. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 100. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 101. Lantheus Medical Imaging Recent Development
    Table 102. Nordion Company Information
    Table 103. Nordion Introduction and Business Overview
    Table 104. Nordion Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 105. Nordion Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 106. Nordion Recent Development
    Table 107. Ntp Radioisotopes Company Information
    Table 108. Ntp Radioisotopes Introduction and Business Overview
    Table 109. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 110. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 111. Ntp Radioisotopes Recent Development
    Table 112. Siemens Healthcare Company Information
    Table 113. Siemens Healthcare Introduction and Business Overview
    Table 114. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 115. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 116. Siemens Healthcare Recent Development
    Table 117. Taiyo Nippon Sanso Corporation Company Information
    Table 118. Taiyo Nippon Sanso Corporation Introduction and Business Overview
    Table 119. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 120. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 121. Taiyo Nippon Sanso Corporation Recent Development
    Table 122. Urenco Limited Company Information
    Table 123. Urenco Limited Introduction and Business Overview
    Table 124. Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 125. Urenco Limited Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 126. Urenco Limited Recent Development
    Table 127. Rotem Industries Company Information
    Table 128. Rotem Industries Introduction and Business Overview
    Table 129. Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 130. Rotem Industries Radiopharmaceuticals in Nuclear Medical Product Offerings
    Table 131. Rotem Industries Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Radiopharmaceuticals in Nuclear Medical Downstream Customers
    Table 135. Radiopharmaceuticals in Nuclear Medical Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Radiopharmaceuticals in Nuclear Medical Product Picture
    Figure 2. Global Radiopharmaceuticals in Nuclear Medical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Radiopharmaceuticals in Nuclear Medical Sales Volume (2019-2030) & (K MT)
    Figure 5. Global Radiopharmaceuticals in Nuclear Medical Sales Price (2019-2030) & (USD/MT)
    Figure 6. Radiopharmaceuticals in Nuclear Medical Report Years Considered
    Figure 7. Global Radiopharmaceuticals in Nuclear Medical Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Radiopharmaceuticals in Nuclear Medical Players Sales Volume Ranking (2023) & (K MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceuticals in Nuclear Medical Revenue in 2023
    Figure 10. Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Diagnostic Radiopharmaceuticals Picture
    Figure 12. Therapy Radiopharmaceuticals Picture
    Figure 13. Enriched Stable Isotopes Picture
    Figure 14. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Radiopharmaceuticals in Nuclear Medical Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
    Figure 17. Global Radiopharmaceuticals in Nuclear Medical Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Radiopharmaceuticals in Nuclear Medical Price by Type (2019-2030) & (USD/MT)
    Figure 19. Product Picture of Diagnostic Application
    Figure 20. Product Picture of Therapeutic Application
    Figure 21. Product Picture of Research
    Figure 22. Product Picture of Pharmaceutical
    Figure 23. Product Picture of Industrial
    Figure 24. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Radiopharmaceuticals in Nuclear Medical Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
    Figure 27. Global Radiopharmaceuticals in Nuclear Medical Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Radiopharmaceuticals in Nuclear Medical Price by Application (2019-2030) & (USD/MT)
    Figure 29. North America Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Volume (%), (2019-2030)
    Figure 41. United States Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
    Figure 62. Radiopharmaceuticals in Nuclear Medical Industrial Chain
    Figure 63. Radiopharmaceuticals in Nuclear Medical Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Description

Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound. Radiopharmacology is the branch of pharmacology that specializes in these agents.

The global market for Radiopharmaceuticals in Nuclear Medical was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceuticals in Nuclear Medical, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Radiopharmaceuticals in Nuclear Medical by region & country, by Type, and by Application.

The Radiopharmaceuticals in Nuclear Medical market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceuticals in Nuclear Medical.

Market Segmentation